Today: 21 March 2026
Browse Category

NASDAQ:KZIA 19 November 2025

KZIA Stock News Today: Kazia Therapeutics Soars on Rare Cancer Response as Nasdaq Delisting Risk Looms

KZIA Stock News Today: Kazia Therapeutics Soars on Rare Cancer Response as Nasdaq Delisting Risk Looms

Kazia Therapeutics reported a rare immune-complete response in a stage IV triple-negative breast cancer patient treated with paxalisib, Keytruda, and chemotherapy. Shares surged over 50% after hours, but the company also disclosed a fresh Nasdaq delisting warning and filed a new prospectus supplement. Kazia plans to request a hearing to contest the delisting.
19 November 2025

Stock Market Today

  • Vital Farms (VITL) Shares Drop 1.39% Amid Market Decline Ahead of Earnings
    March 20, 2026, 7:40 PM EDT. Vital Farms (VITL) shares slid 1.39% to $31.98, underperforming the S&P 500's 0.29% dip. Despite this, the stock gained 4.75% over the past month, outpacing the Consumer Staples sector's 3.54% rise. Investors eye upcoming earnings, with an EPS forecast of $0.14, up 40% year-over-year, and projected revenue of $142 million, up 28.6%. Full-year estimates show expected EPS of $1.11 and revenue near $595.7 million, increases of 88.1% and 26.3%. Vital Farms holds a Zacks Rank of #3 (Hold) with a forward price-to-earnings (P/E) ratio of 29.35, reflecting a premium to its industry's average of 18.42. The consumer staples industry's strong Zacks Industry Rank at 90 places it in the top 36% of sectors, driving investor interest ahead of earnings.
Go toTop